Acarbose and Collapse - a phase IV clinical study of FDA data

Summary:

Collapse is found among people who take Acarbose, especially for people who are female, 60+ old.

The phase IV clinical study analyzes which people take Acarbose and have Collapse. It is created by eHealthMe based on reports of 3,996 people who have side effects when taking Acarbose from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 03, 2022

3,996 people reported to have side effects when taking Acarbose.
Among them, 6 people (0.15%) have Collapse.


What is Acarbose?

Acarbose has active ingredients of acarbose. It is often used in diabetes. eHealthMe is studying from 4,047 Acarbose users for its effectiveness, alternative drugs and more.

What is Collapse?

Collapse (sudden functional breakdown) is found to be associated with 798 drugs and 91 conditions by eHealthMe.

Number of Acarbose and Collapse reports submitted per year:

Could Acarbose cause Collapse?

Gender of people who have Collapse when taking Acarbose *:

  • female: 66.67 %
  • male: 33.33 %

Age of people who have Collapse when taking Acarbose *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 40 %
  • 50-59: 0.0 %
  • 60+: 60 %

Common drugs people take besides Acarbose *:

  1. Amaryl: 2 people, 33.33%
  2. Gliclazide: 1 person, 16.67%
  3. Amlodipine: 1 person, 16.67%
  4. Arimidex: 1 person, 16.67%
  5. Avandia: 1 person, 16.67%
  6. Dothiepin Hydrochloride: 1 person, 16.67%
  7. Doxazosin Mesylate: 1 person, 16.67%
  8. Enalapril Maleate: 1 person, 16.67%
  9. Furosemide: 1 person, 16.67%
  10. Voltaren: 1 person, 16.67%

Common side effects people have besides Collapse *:

  1. Weakness: 2 people, 33.33%
  2. Sudden Death Unexplained: 2 people, 33.33%
  3. Speech Impairment (Adult) (inability to speak (adult)): 2 people, 33.33%
  4. Cerebral Infarction (less blood supply to brain resulting tissue damage): 2 people, 33.33%
  5. Haemorrhagic Stroke (stroke caused by the rupture of a blood vessel in the brain): 1 person, 16.67%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 16.67%
  7. Bleeding Into The Skin: 1 person, 16.67%
  8. Breathing Sounds - Abnormal (Stridor): 1 person, 16.67%
  9. Cardiac Arrest: 1 person, 16.67%
  10. Cerebral Artery Occlusion (blockage of blood vessel of brain by fat or clot): 1 person, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Acarbose and have Collapse?

Check whether Collapse is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Collapse and when was it recovered:

Expand to all the drugs that have ingredients of acarbose:

Alternative drugs to, pros and cons of Acarbose:

Common Acarbose side effects:

Browse all side effects of Acarbose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Collapse treatments and more:

COVID vaccines that are related to Collapse:

Common drugs associated with Collapse:

All the drugs that are associated with Collapse:

All the conditions that are associated with Collapse:

How the study uses the data?

The study uses data from the FDA. It is based on acarbose (the active ingredients of Acarbose) and Acarbose (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: